Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge
- PMID: 19001792
- DOI: 10.1159/000170386
Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge
Abstract
Background: We investigated the anti-inflammatory potential of n-3 polyunsaturated fatty acids (PUFA) on specific bronchial inflammation. Allergic asthmatics were challenged using a low-dose allergen provocation model.
Methods: Our parallel double-blinded study randomly assigned 23 house dust mite-allergic asthmatics (aged 22-29 years; 13 females, 10 males) to dietary supplementation with either an n-3 PUFA-enriched fat blend (0.69 g/day) or placebo for 5 weeks. After 3 weeks, the patients were challenged daily with low doses of mite allergen for 2 weeks. Primary outcome parameters were effects on lung function (forced expiratory volume in 1 s, FEV(1)) and exhaled nitric oxide (eNO) as a marker of bronchial inflammation.
Results: Even before the bronchial challenge, eNO was significantly lower in the n-3 PUFA group (p=0.014). Levels of eNO increased during allergen exposure in both groups, but differences in means were significantly lower in the n-3 PUFA group (p=0.022). During the low-dose allergen challenge, there were no differences between the groups with regard to symptoms, FEV(1) or the allergen dose required to induce deterioration of lung function (PD(20)). Numbers of sputum eosinophils did not differ significantly, while serum eosinophils (10.1+/-0.1.84 vs. 5.79+/-0.69%) as well as changes in eosinophilic cationic protein (20.5+/-9.93 vs. -1.68+/-4.36 ng/ml) and in vitro cysteinyl leukotriene release (2,889+/-872 vs. 1,120+/-173 ng/ml) were significantly lower in the n-3 PUFA group (p<0.05 each).
Conclusion: Our results provide evidence that dietary supplementation with n-3 PUFA is able to reduce bronchial inflammation even after low-dose allergen challenge.
Copyright 2008 S. Karger AG, Basel.
Similar articles
-
Indices of lower airway inflammation in children monosensitized to house dust mite after nasal allergen challenge.Allergy. 2008 Oct;63(10):1345-51. doi: 10.1111/j.1398-9995.2008.01694.x. Allergy. 2008. PMID: 18782114
-
Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4.Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):154-7. doi: 10.1097/ACI.0b013e3282f60f61. Curr Opin Allergy Clin Immunol. 2008. PMID: 18317025 Review.
-
Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.Respir Med. 2007 Jul;101(7):1600-8. doi: 10.1016/j.rmed.2006.06.006. Epub 2007 May 7. Respir Med. 2007. PMID: 17482451
-
Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.Clin Exp Allergy. 2005 Aug;35(8):1080-7. doi: 10.1111/j.1365-2222.2005.02296.x. Clin Exp Allergy. 2005. PMID: 16120091 Clinical Trial.
-
Dietary omega-3 polyunsaturated fatty acid supplementation and airway hyperresponsiveness in asthma.J Asthma. 2005 Jun;42(5):305-14. doi: 10.1081/JAS-62950. J Asthma. 2005. PMID: 16036405 Review.
Cited by
-
Association between circulating fatty acid metabolites and asthma risk: a two-sample bidirectional Mendelian randomization study.BMC Med Genomics. 2023 May 23;16(1):112. doi: 10.1186/s12920-023-01545-4. BMC Med Genomics. 2023. PMID: 37221513 Free PMC article.
-
Effect of Omega-3 Polyunsaturated Fatty Acids Intake on Eosinophil Airway Inflammation in University Athletes.J Clin Med Res. 2022 Nov;14(11):466-473. doi: 10.14740/jocmr4825. Epub 2022 Nov 29. J Clin Med Res. 2022. PMID: 36578368 Free PMC article.
-
Assessing the Anti-Inflammatory Effects of an Orally Dosed Enzymatically Liberated Fish Oil in a House Dust Model of Allergic Asthma.Biomedicines. 2022 Oct 14;10(10):2574. doi: 10.3390/biomedicines10102574. Biomedicines. 2022. PMID: 36289834 Free PMC article.
-
Activation of Free Fatty Acid Receptor 4 (FFA4) Ameliorates Ovalbumin-Induced Allergic Asthma by Suppressing Activation of Dendritic and Mast Cells in Mice.Int J Mol Sci. 2022 May 9;23(9):5270. doi: 10.3390/ijms23095270. Int J Mol Sci. 2022. PMID: 35563671 Free PMC article.
-
Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction.Rev Bras Farmacogn. 2022;32(1):50-64. doi: 10.1007/s43450-021-00213-x. Epub 2021 Dec 2. Rev Bras Farmacogn. 2022. PMID: 34876760 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical